As the PI3K and mTOR pathways play a significant role in tumor angiogenesis [54], [55], we examined the effects of NVP-BEZ235 treatment on microvessel density (MVD) through immunohistochemistry for the endothelial marker CD31. This evidence concerns the gene MTOR and neoplasm.